Amalgamated Bank Iovance Biotherapeutics, Inc. Put Options Transaction History
Amalgamated Bank
- $13.6 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding IOVA
# of Institutions
281Shares Held
222MCall Options Held
1.07MPut Options Held
1.15M-
Mhr Fund Management LLC New York, NY29MShares$69.8 Million8.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.1MShares$58 Million0.0% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$51.2 Million0.0% of portfolio
-
State Street Corp Boston, MA13.3MShares$32.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny9.33MShares$22.5 Million0.01% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $380M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...